The level of superoxide dismutase and catalase in acyanotic congenital heart disease children with heart failur

Henry  Wicaksono; Mahrus A  Rahman; Roedi  Irawan; I Ketut Alit  Utamayasa; Teddy  Ontoseno; Taufiq  Hidayat

doi:10.30574/gscbps.2021.16.1.0206

Authors

Henry Wicaksono Department of Child Health, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Hospital, Surabaya, Indonesia.
Mahrus A Rahman Department of Child Health, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Hospital, Surabaya, Indonesia.
Roedi Irawan Department of Child Health, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Hospital, Surabaya, Indonesia.
I Ketut Alit Utamayasa Department of Child Health, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Hospital, Surabaya, Indonesia.
Teddy Ontoseno Department of Child Health, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Hospital, Surabaya, Indonesia.
Taufiq Hidayat Department of Child Health, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Hospital, Surabaya, Indonesia.

DOI:

https://doi.org/10.30574/gscbps.2021.16.1.0206

Keywords:

SOD, CAT, Acyanotic CHD, Heart failure, Oxidative stress, Children

Abstract

Background: The most common complication in acyanotic congenital heart disease (CHD) is heart failure which definitive diagnosis and therapy remain unsatisfactory. Heart failure’s progression is often associated with oxidative stress process. Superoxide dismutase (SOD) is the first line antioxidant of defense against superoxide anion. While Catalase (CAT) breaks down hydrogen peroxide into water and oxygen molecules which complements previous detoxification carried out by SOD.

Objective: This study aimed to compare the differences of SOD and CAT levels in acyanotic CHD patients between those with and without heart failure.

Methods: A case-control study was conducted on three to ten years old children with a left-to-right shunt acyanotic CHD with and without heart failure in the Pediatric Cardiology outpatient clinic, ward, and emergency room of Dr. Soetomo Hospital Surabaya from April-July 2020. Echocardiography was used to establish the diagnosis of CHD, while Pediatric Heart Failure Score (PHFS) criteria was used to indicate heart failure. T-test was undertaken for analysing the difference between both groups.

Results: The total samples were 41 children, consisted of 29 subjects in the case group (CHD with heart failure) and 12 subjects in the control group (without heart failure). The level of SOD in CHD with heart failure was lower (74.670+15.705) than those without it (109.163+3.111) (p<0.05). In contrast, level of CAT in CHD with heart failure was higher (25.895) than those without it (13.976) (p<0.05).

Conclusion: There was a significant difference of SOD and CAT levels in acyanotic CHD between those with and without heart failure.

Metrics

Metrics Loading ...

References

Hinton RB, Ware SM. Heart failure in pediatric patients with congenital heart disease. Circ Res. 2017; 15: 978-994.

Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003; 348: 1647–1655.

Rossano JW, Kim JJ, Decker JA, Price JF, Zafar F, Graves DE. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012; 18: 459–470.

Nandi D, Rossano JW. Epidemiology and cost of heart failure in children. Cardiol Young. 2015; 25(8): 1460–1468.

Kantor PF, Lougheed J, Dancea A, McGillion N, Barbosa N, Chan C, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines. Can J Cardiol. 2013; 29(12): 1535–1552.

Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006; 296(15): 1867–1876.

Park MK. Park’ s pediatric cardiology for practitioners. 6th ed. Elsivier, Texas. 2021.

Ross RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol. 2012; 33(8): 1295–1300.

Sharma S, Grobe AC, Wiseman DA, Kumar S, Englaish M, Najwer I, et al. Lung antioxidant enzymes are regulated by development and increased pulmonary blood flow. Lung Cell Mol Physiol. 2007; 293: 960–971.

Fukai T, Ushio M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxidants & Redoks Signaling. 2011; 15(6): 1-24.

Mendez JI, Nicholson WJ, Taylor WR. SOD isoforms and signalling in blood vessels: evidence for the importance of ROS compartmentalization. Arterioscler Thromb Vasc Biol. 2005; 25: 887–888.

Gao-Zhong L, Dong XY, Yang S, Chen YQ, Lu JP. Erythrocyte oxidative stress in children with left to right shunt congenital heart disease. Int J Contemp Pediatr. 2010; 12: 440-443.

Ighodaro OM and Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence Grid. Alex J Med. 2018; 54(4): 287-293.

Tsutsui H, Kinugawa S, and Matsushima S. Oxidative stress and heart Failure. Am J Physiol Heart Circ Physiol. 2011; 301: 2181–2190.

Diaconu C. Oxidative stress and heart failure. Arch Balk Med Union. 2019; 54(2): 219-221.